News + Filings Transactions Holdings
|
Wilson John Robert
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | Marker Therapeutics, Inc. | MRKR | Grant | Stock Option (right to buy) | 8k | $1.72 | $13.8k | | 06/06/2023 |
| 05/24/2022 | Marker Therapeutics, Inc. | MRKR | Grant | Stock Option (Right to Buy) | 80k | $0.34 | $27k | | 05/24/2022 |
| 06/08/2021 | Marker Therapeutics, Inc. | MRKR | Grant | Common Stock | 12.7k | $0.00 | $0 | | 06/08/2021 |
| 05/25/2021 | Allovir, Inc. | ALVR | Grant | Stock Option (Right to Buy) | 22.5k | $21.51 | $484k | | 05/25/2021 |
| 03/16/2021 | Marker Therapeutics, Inc. | MRKR | Purchase | Common Stock | 1.7M | $1.75 | $3M | | 03/16/2021 |
| 03/11/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 10.2k | $30.87 | $314.5k | See Footnote | 03/09/2021 |
| 03/11/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 3.4k | $30.87 | $104.9k | See Footnote | 03/09/2021 |
| 03/11/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 2.3k | $31.63 | $73k | See Footnote | 03/09/2021 |
| 03/11/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 769 | $31.63 | $24.3k | See Footnote | 03/09/2021 |
| 03/10/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 28.4k | $30.93 | $878.4k | See Footnote | 03/09/2021 |
| 03/10/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 9.5k | $30.93 | $292.8k | See Footnote | 03/09/2021 |
| 03/10/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 25.3k | $31.59 | $797.9k | See Footnote | 03/09/2021 |
| 03/10/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 8.4k | $31.59 | $266k | See Footnote | 03/09/2021 |
| 03/10/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 900 | $32.31 | $29.1k | See Footnote | 03/09/2021 |
| 03/10/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 300 | $32.31 | $9.7k | See Footnote | 03/09/2021 |
| 03/09/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 52.4k | $31.30 | $1.6M | See Footnote | 03/09/2021 |
| 03/09/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 17.5k | $31.30 | $547.1k | See Footnote | 03/09/2021 |
| 03/09/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 30.5k | $31.70 | $966.9k | See Footnote | 03/09/2021 |
| 03/09/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 10.2k | $31.70 | $322.3k | See Footnote | 03/09/2021 |
| 08/03/2020 | Allovir, Inc. | ALVR | Conversion | Common Stock | 3.2M | $0.00 | $0 | | 08/03/2020 |
| 08/03/2020 | Allovir, Inc. | ALVR | Conversion | Common Stock | 2.3M | $0.00 | $0 | By Trust | 08/03/2020 |
| 08/03/2020 | Allovir, Inc. | ALVR | Conversion | Series A-3 Convertible Preferred Stock | 4.7M | $0.00 | $0 | | 08/03/2020 |
| 08/03/2020 | Allovir, Inc. | ALVR | Conversion | Series A-3 Convertible Preferred Stock | 3.5M | $0.00 | $0 | By Trust | 08/03/2020 |
| 07/29/2020 | Allovir, Inc. | ALVR | Grant | Stock Option (Right to Buy) | 22.5k | $17.00 | $382.5k | | 07/29/2020 |
| 05/09/2019 | Marker Therapeutics, Inc. | MRKR | Grant | Common Stock | 7.3k | $0.00 | $0 | | 05/09/2019 |
| 10/17/2018 | Marker Therapeutics, Inc. | MRKR | Grant | | 12.5k | $8.34 | $104.2k | | 10/17/2018 |
|